Rifamixin, a nonabsorbed oral antibiotic, is effective for preventing traveler's diarrhea, according to new research.
By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD
Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Associate Clinical Professor of Medicine, University of California, San Francisco; Dr. Chan is Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA. Drs. Chan and Elliott report no financial relationships to this field of study.
A synthetic analog of human amylin has been approved for the treatment of type 1 and type 2 diabetics.
Pramlintide is a 37-amino acid peptide which differs from human amylin with substitution of three amino acids at positions 25, 28, and 29. It represents the first of a new class of amylinomimetic antidiabetic compounds. It is marketed by Amylin Pharmaceuticals, Inc as Symlin.
Roche is Under Pressure Over Its Antiviral Drug Tamiflu; ACE Inhibitors or ARBs for Prediabetics?; Xigris is Approved for Severe Sepsis; ACE Inhibitors Inhibiting Aortic Valve Stenosis?; FDA Actions
Beta-Blockers May Be Useful for Noncardiac Surgery; Promising New Weight Loss Drug?; Treating Shift-Work Disorder; Another Flu Vaccine Shortage?; FDA Actions
Staphylococcal Toxins in Patients with Psoriasis, Atopic Dermatitis, Erythroderma, and in Healthy Control Subjects; Insulin Resistance and Risk of Congestive Heart Failure; Ciprofloxacin Interacts with Thyroid Replacement Therapy